Dr. Richard Glickman
Equibles does not estimate personal net worth.
Get an email with a short summary when enGene Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get ENGN alertsAbout Dr. Richard Glickman
enGene Therapeutics Inc. reported in an 8-K filed July 16, 2026 that Dr. Richard Glickman resigned as director, effective July 15, 2026. enGene Therapeutics Inc. reported in an 8-K filed July 16, 2026 that Dr. Richard Glickman resigned as chairman of the Board of Directors, effective July 15, 2026. enGene Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at enGene Therapeutics Inc. includes Ron Cooper (CEO and Board Member), Ronald H. W. Cooper (CEO and Board Member), Ronald H.W. Cooper (CEO and Board Member) and 7 others.
“On July 15, 2026, Dr. Richard Glickman resigned as a director and chairman of the Board of Directors (the "Board") of enGene Therapeutics Inc. (the "Company"), including as a member of any committee of the Board.”
“On July 15, 2026, Dr. Richard Glickman resigned as a director and chairman of the Board of Directors (the "Board") of enGene Therapeutics Inc. (the "Company"), including as a member of any committee of the Board.”
Affiliation history
-
enGene Therapeutics Inc. (ENGN)
SEC 8-K
Current2023-10-31–present
-
Start not stated–2026-07-15
-
Start not stated–2026-07-15
Company network
Leadership on record at enGene Therapeutics Inc.
- Ron Cooper CEO, Board Member
- Ronald H. W. Cooper CEO, Board Member
- Ronald H.W. Cooper CEO, Board Member
- Ryan Daws CFO
- Alex Nichols COO
- Alexander Nichols COO
- Dr. Alex Nichols COO
- Anthony Cheung CTO
- Joan Connolly CTO
- Dr. William Grossman Board Member